The 1836 Dispatch

    The Science

    Does Biological Age Testing Actually Work? What the Evidence Says, and What a Number Can and Cannot Tell You

    Epigenetic clocks, blood-marker scores and the "you are 9 years older than your birthday" result: what the research supports, where it breaks down, and how to use a number without being used by it.

    By Stacy Pleasant, FNP-C·

    Reviewed by Stacy Pleasant, MSN, FNP-C, APRN. Educational content. This article summarizes published research on biological age measurement and does not diagnose any condition, predict any individual's lifespan, or recommend any treatment. Decisions about testing and follow-up belong in a conversation with a licensed clinician who knows your history.

    Someone you know has taken a test and been told they are seven years younger than their birthday, or nine years older. The number is memorable, which is the point. The question underneath it is harder: does biological age testing actually work?

    The short answer is that it depends on what you mean by "work." As a research instrument for comparing groups of people, the best of these tests perform well and have for a decade. As a precise readout for one person on one day, they carry more measurement noise than the marketing admits, different tests disagree with each other, and no trial has yet shown that lowering the number leads to fewer diseases or a longer life. Both halves of that answer are supported by the same literature, and this article walks through it.

    In this article

    1. What "biological age" means, and what it does not
    2. The kinds of tests you can actually buy
    3. What the tests do well: risk in groups
    4. Where they break down: one person, different numbers
    5. Can you move the number, and does moving it matter?
    6. The blood-marker route: why PhenoAge is different
    7. How 1836 summarizes blood-marker results, and the limits it states
    8. What to do with a result
    9. Frequently asked questions

    What "biological age" means, and what it does not

    Chronological age is the number of years since you were born. Biological age is an estimate of how far along a body is in the biological processes that track with aging, expressed in years so that it can be compared with the calendar. That last clause is the whole trick. Nothing in your blood says "48." A model says it, after being trained on thousands of people to find the combination of measurements that best lines up with their ages, or with how long they went on to live.

    So a biological age is a model output, not a measurement of a physical quantity like blood pressure. Two consequences follow. First, different models produce different numbers from the same sample, because they were trained on different data toward different targets. Second, the result inherits every weakness of the model's training set and the measurement it runs on. Neither of those makes the number useless. They make it a number with error bars, and the error bars are the part most people never see.

    Anne Brunet, who co-directs the Paul F. Glenn Center for the Biology of Aging Research at Stanford, put it plainly in a September 2026 interview: "People need to understand that it's more complex than this one number."

    The kinds of tests you can actually buy

    Four families of tests carry the "biological age" label. They are not interchangeable.

    Epigenetic clocks (DNA methylation). These read chemical marks on DNA from a blood or saliva sample and feed several hundred of them into a model. The first widely used version, published by Steve Horvath in 2013, used 353 methylation sites and predicted chronological age across 51 tissue types with a correlation of 0.96 and a median error of 3.6 years. Later "second generation" clocks such as PhenoAge (2018) and GrimAge (2019) were trained to predict mortality and disease rather than the calendar, and "third generation" measures such as DunedinPACE (2022) estimate the pace of aging rather than an age. Most direct-to-consumer kits sold as biological age tests are epigenetic clocks of one of these generations.

    Blood-marker scores. These use routine clinical chemistry, the kind of markers on an ordinary lab panel, combined in a formula trained against mortality. The reference example is the clinical PhenoAge score from Levine and colleagues, which uses nine common markers plus chronological age. Practices, including 1836, also publish their own composite scores built from the markers they measure; those are practice-defined and are not the same thing as a validated research clock.

    Telomere length. Older and cheaper, and now regarded as a weak individual-level marker because telomere length varies widely between healthy people of the same age and is measured with poor reproducibility across labs.

    Organ-specific and proteomic clocks. Newer research measures that estimate the age of individual organ systems from proteins in blood. These are promising in cohort studies and are, as of this writing, research tools rather than consumer products with an established track record.

    When someone says "I took a biological age test," the first question to ask is which of these four it was, and the second is which model inside that family.

    What the tests do well: risk in groups

    This is the part the skeptics sometimes skip. In large cohorts, the better clocks are real predictors.

    PhenoAge, trained in the NHANES III cohort with more than 23 years of mortality follow-up, was associated with a 4.5 percent higher risk of all-cause mortality for every additional year of age acceleration, independent of chronological age. The authors reported that it "strongly outperforms previous measures in regards to predictions for a variety of aging outcomes, including all-cause mortality, cancers, healthspan, physical functioning, and Alzheimer's disease."

    DunedinPACE, built from 19 biomarkers tracked over 20 years in a single birth cohort, "was associated with morbidity, disability, and mortality" in its validation samples, and reported a test-retest reliability (intraclass correlation) of 0.96, which is unusually high for this class of measurement because its designers deliberately excluded methylation sites that reproduce poorly.

    The Biomarkers of Aging Consortium's 2024 review in Nature Medicine takes the same position from the other direction: the research value is established, the clinical translation is not. Its authors write that "no consensus exists on how biomarkers of aging should be validated before their translation to the clinic," and lay out a three-step path of analytical validity, clinical validity and clinical utility that no current clock has completed end to end.

    Horvath himself, speaking to The Scientist in 2026, drew the line in one sentence: "There's no question that epigenetic clocks perform very well in epidemiological studies. But what the field has not yet achieved is really what one would call reference standards."

    That is the honest summary. If you enrolled 10,000 people and sorted them by a good clock, the fast-aging group would have more heart disease and die sooner than the slow-aging group. Whether the clock can tell you, one person, where you sit is the next question.

    Where they break down: one person, different numbers

    Three separate problems stack up when a group-level tool is sold as an individual readout.

    Technical noise. In 2022, a team led by Albert Higgins-Chen at Yale ran the same DNA sample through the standard clocks more than once and found that "technical noise produces deviations up to 9 years between replicates for six prominent epigenetic clocks." Their corrected versions, built on principal components, brought "agreement between most replicates within 1.5 years," but that correction is not what most consumer kits report. David Rehkopf, a Stanford epidemiologist, puts the built-in error of a typical epigenetic clock at roughly three years. For a test that might tell you that you are four years younger than your birthday, three years of noise is most of the signal.

    Different clocks, different answers. The same sample scored on Horvath, PhenoAge and GrimAge will produce three different ages, sometimes on opposite sides of your chronological age, because each was trained to a different target. The Scientist's 2026 reporting lists the reasons: different model generations, blood versus saliva (saliva is roughly a third epithelial cells, blood is entirely immune cells, and methylation differs by cell type), array versus sequencing measurement, and the absence of any reference standard across labs. A consumer who gets "biological age 41" from one company and "biological age 49" from another has not learned that one is wrong. Both are what those models produce.

    The framing problem. The December 2025 AMA Journal of Ethics article on epigenetic age testing argues that companies "misrepresent results by framing them as discovering one's 'actual' or 'real' age, when results merely indicate probabilistic health risks," and warns that the framing "can easily lead to patient misunderstandings that can increase risks of psychological harm." The number is a risk index dressed as a birthday. Read it as the former.

    Two further cautions from the Stanford interview are worth carrying. Epigenetic tests measure blood cell DNA, so they say nothing organ-specific. And they lag: the clocks change slowly, so a result taken this month reflects years of history, not the last eight weeks of better sleep.

    Can you move the number, and does moving it matter?

    There is one randomized trial that answers the first half of this question with a validated measure, and it is the right one to know.

    CALERIE was a two-year randomized trial of 25 percent calorie restriction in 220 non-obese adults. The 2023 analysis in Nature Aging found that the intervention "slowed the pace of aging, as measured by the DunedinPACE DNAm clock," with a change that "suggest[s] a ~3% slowing of the pace of aging." The same intervention "did not lead to significant changes in PhenoAge- or GrimAge-clock-measured biological age."

    Read that carefully. A demanding two-year intervention moved one validated measure by about three percent and did not move two others. That is what real change looks like on these instruments: small, slow, and visible only on the measure designed to detect pace. Anyone reporting a ten-year drop in biological age over a few months is reporting noise, a change of test, or a change of model.

    The second half of the question is open. As a 2025 review in Forbes by a physician-author summarized, "No clinical trial has demonstrated that interventions reducing epigenetic age lead to fewer diseases or longer life." Lowering a clock score is not yet an outcome. It is a surrogate, and surrogates in medicine have a mixed record.

    The blood-marker route: why PhenoAge is different

    There is a version of biological age testing that most people already have the raw data for, and it deserves its own section because it behaves differently from the epigenetic kits.

    The clinical PhenoAge score uses nine markers that appear on a routine panel: albumin, creatinine, glucose, C-reactive protein, lymphocyte percentage, mean cell volume, red cell distribution width, alkaline phosphatase and white blood cell count, plus chronological age. Levine's group built it in NHANES III against mortality, then trained the DNA methylation version to predict it. That is a real advantage for a patient: every input is a familiar, interpretable clinical measurement with its own reference range and its own clinical meaning, so a high score points to specific markers you can look at rather than to a black box.

    It also has the ordinary limits of blood work. Several of those markers move with hydration, a recent infection, a poor night's sleep or the time since your last meal, so the score moves with them. A blood-marker age is a snapshot of state, taken under conditions that matter, which is why the collection conditions should be the same every time the number is compared.

    1836's own results reporting sits closer to this category than to the epigenetic kits, although it does not produce an age.

    How 1836 summarizes blood-marker results, and the limits it states

    1836 does not report a biological age. The science page describes what it does instead: Labcorp biomarker testing, practice-defined domain scores and ASCVD risk scoring, reviewed by telehealth. The Focused Assessment and the Comprehensive Assessment name their Labcorp tests up front, and your clinician may add or remove tests based on your history. Findings are organized across seven health areas (metabolic health, cardiovascular, inflammation, hormonal, organ function, blood health and body composition) and summarized in composite scores from 0 to 100 within a practice-defined reporting framework. Where the calculator is appropriate for the patient, an ASCVD risk estimate is considered alongside them.

    The same page states the limits in its own words, and they are worth quoting rather than paraphrasing: the weights and score bands "are not independently validated diagnostic thresholds"; the domain scores "are not validated diagnoses, predictors of lifespan or proof of treatment benefit"; and a higher score "is not proof of better long-term health."

    That is a different claim from the one on a consumer kit box, and deliberately so. The 1836 scores are a way of organizing many results into a conversation with a clinician, built from measurements you can see and act on individually. They are not a research clock, they have not been validated against mortality the way PhenoAge or DunedinPACE have, and they do not pretend to be. What they offer instead is the underlying data: every domain score points back to named tests with laboratory reference ranges, reviewed with your clinician by video.

    What to do with a result

    If you already have a biological age number from any source, five rules keep it useful.

    Ask which test and which model. An epigenetic clock, a blood-marker score and a practice-defined composite are three different objects. Comparing a number from one to a number from another tells you nothing.

    Treat the first result as a baseline, not a verdict. With three years of noise on a typical epigenetic clock, one reading cannot distinguish "four years younger" from "about my age." Two readings, same test, same lab, same conditions, a year apart, begin to show a direction.

    Look underneath the number. For a blood-marker score, the inputs are the point. A high score with an elevated C-reactive protein and a low albumin is a conversation about inflammation and nutrition, which is actionable. The composite alone is not.

    Expect slow movement. The best-run trial in the field moved a validated pace-of-aging measure by about three percent over two years. Anything faster is measurement, not biology.

    Do not skip the screening that has evidence behind it. Blood pressure, lipids, glucose, colorectal and other recommended screenings have decades of outcome data. No biological age test does. A biological age result is an addition to that schedule, not a replacement for it, and 1836's own guidance says the same: this service does not replace routine screening, primary care or urgent evaluation.

    For readers who want the underlying markers rather than a single number, the Focused Assessment is the entry point: named Labcorp tests, a mobile blood draw at your home, office or another location you choose, and a results review with your clinician by video. The Comprehensive Assessment adds hormone, thyroid and nutrient testing; compare the two.

    Frequently asked questions

    Are biological age tests accurate? In groups, yes: the better epigenetic clocks and blood-marker scores predict mortality and disease across large cohorts, and PhenoAge was associated with 4.5 percent higher all-cause mortality risk per year of age acceleration in NHANES III. For one individual, less so: replicate samples of the same blood have differed by up to 9 years on standard clocks, a Stanford epidemiologist estimates about three years of built-in error, and different clocks give different answers for the same person. Read a single result as an estimate with a several-year margin.

    Can you reverse your biological age? No study has shown that. The CALERIE trial, a two-year randomized trial of 25 percent calorie restriction in 220 adults, slowed one validated pace-of-aging measure (DunedinPACE) by about three percent and did not significantly change PhenoAge or GrimAge. No clinical trial has yet shown that lowering an epigenetic age leads to fewer diseases or a longer life. Claims of reversing biological age by many years in months describe measurement noise or a change of test, not established biology.

    What is the difference between an epigenetic age test and a blood-marker biological age? An epigenetic test reads DNA methylation marks from blood or saliva and runs them through a trained clock model. A blood-marker biological age, such as the clinical PhenoAge score, combines routine lab values (albumin, creatinine, glucose, C-reactive protein, several blood-count measures and alkaline phosphatase) with chronological age. The blood-marker version is more transparent, because each input is a familiar marker you can inspect, but it is also more sensitive to short-term conditions like hydration and recent illness.

    Is a biological age test worth it? As motivation and as a baseline, it can be, provided you know which test you took and repeat it under the same conditions. As a medical decision tool, it is not there yet: the 2024 Nature Medicine review from the Biomarkers of Aging Consortium states that no consensus exists on how these biomarkers should be validated before clinical use, and no biological age test is an approved diagnostic. Recommended screenings with outcome evidence come first; a biological age estimate comes after them.


    Reviewed by Stacy Pleasant, MSN, FNP-C, APRN. This article is educational and is not medical advice, a diagnosis, a lifespan prediction, or a treatment recommendation. Testing and follow-up decisions should be made with a licensed clinician who knows your history.

    Want the markers behind the number? Book your assessment: the Focused Assessment covers core metabolic testing, and the Comprehensive Assessment adds hormone, thyroid and nutrient testing, each with a mobile blood draw at your home, office or another location you choose.

    Sources

    Horvath S. DNA methylation age of human tissues and cell types. Genome Biology 2013;14:R115. https://link.springer.com/article/10.1186/gb-2013-14-10-r115

    Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging 2018;10(4):573-591. https://www.aging-us.com/article/101414/text

    Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife 2022;11:e73420. https://elifesciences.org/articles/73420

    Higgins-Chen AT, Thrush KL, Wang Y, et al. A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nature Aging 2022;2:644-661. https://www.nature.com/articles/s43587-022-00248-2

    Waziry R, Ryan CP, Corcoran DL, et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nature Aging 2023;3:248-257. https://www.nature.com/articles/s43587-022-00357-y

    Moqri M, Herzog C, Poganik JR, et al. Validation of biomarkers of aging. Nature Medicine 2024;30:360-372. https://www.nature.com/articles/s41591-023-02784-9

    Stanford Report. What biological age tests can, and can't, tell you (September 23, 2026). https://news.stanford.edu/stories/2026/09/biological-age-tests-tips-advice

    The Scientist. Epigenetic clocks power biological age data, but why do results differ across tests? (2026). https://www.the-scientist.com/epigenetic-clocks-power-biological-age-data-but-why-do-results-differ-across-tests-74347

    Hauskeller M, Shore L. What are the most ethically salient implications of epigenetic age testing? AMA Journal of Ethics, December 2025. https://journalofethics.ama-assn.org/article/what-are-most-ethically-salient-implications-epigenetic-age-testing/2025-12

    Pines JM. Are biological age tests worth it? Here's what the research says. Forbes, December 10, 2025. https://www.forbes.com/sites/jessepines/2025/12/10/are-biological-age-tests-worth-it-here-is-what-the-research-says/

    1836 Wellness. Biomarkers and Lab Testing Science. https://1836wellness.com/science

    This article is educational and is not medical advice, a diagnosis, or a treatment recommendation. Lab values and ranges discussed here are general; only a licensed clinician who has reviewed your own labs and history can tell you what your results mean. If you are experiencing a medical emergency, call 911.

    Take the next step

    Ready to discuss your results and next steps?

    The Focused Assessment ($349 at a Labcorp center) includes clinician-ordered lab testing and a results review with Stacy Pleasant, FNP-C, a board-certified family nurse practitioner. Appointments are by scheduled video for eligible Texas patients. Your blood is drawn at a Labcorp patient service center near you that you book (a morning visit, fasting), or our phlebotomist draws it at your home or office for $120 more. A home or office draw depends on ZIP code and availability.